Teva Pharmaceutical Industries Ltd (TEVA) stock has fallen -63.04% over the last 12 months, and the average rating from Wall Street analysts is a Hold. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives TEVA stock a score of 37 out of a possible 100.
That score is mainly influenced by a long-term technical score of 3. TEVA’s score also includes a short-term technical score of 8. The fundamental score for TEVA is 99. In addition to the average rating from Wall Street analysts, TEVA stock has a mean target price of $18.26. This means analysts expect the stock to add 113.07% over the next 12 months.
What’s Happening with TEVA Stock Today
Teva Pharmaceutical Industries Ltd (TEVA) stock has fallen -5.62% while the S&P 500 has fallen -0.17% as of 11:55 AM on Wednesday, Jun 12. TEVA has fallen -$0.51 from the previous closing price of $9.08 on volume of 17,599,268 shares. Over the past year the S&P 500 is up 3.55% while TEVA has fallen -63.04%. TEVA lost -$3.46 per share in the over the last 12 months.